By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Vaccine developer Affiris will use Probiogen's Human Artificial Lymph Node Technology (HuALN) as an analytical tool to find targets for its Affitome vaccination project, Affiris said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.
A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.
Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.
An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.